AU4143397A - New pharmaceutically active compounds - Google Patents

New pharmaceutically active compounds

Info

Publication number
AU4143397A
AU4143397A AU41433/97A AU4143397A AU4143397A AU 4143397 A AU4143397 A AU 4143397A AU 41433/97 A AU41433/97 A AU 41433/97A AU 4143397 A AU4143397 A AU 4143397A AU 4143397 A AU4143397 A AU 4143397A
Authority
AU
Australia
Prior art keywords
active compounds
pharmaceutically active
new pharmaceutically
new
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41433/97A
Inventor
Hakan Bergstrand
Kostas Karabelas
Margareta Linden
Michael Lofthagen
Peter Sjo
Mats Thelin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Publication of AU4143397A publication Critical patent/AU4143397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU41433/97A 1996-09-10 1997-09-08 New pharmaceutically active compounds Abandoned AU4143397A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9603285A SE9603285D0 (en) 1996-09-10 1996-09-10 New compounds
SE9603285 1996-09-10
PCT/SE1997/001506 WO1998011103A1 (en) 1996-09-10 1997-09-08 New pharmaceutically active compounds

Publications (1)

Publication Number Publication Date
AU4143397A true AU4143397A (en) 1998-04-02

Family

ID=20403830

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41433/97A Abandoned AU4143397A (en) 1996-09-10 1997-09-08 New pharmaceutically active compounds

Country Status (6)

Country Link
AR (1) AR009732A1 (en)
AU (1) AU4143397A (en)
SA (1) SA97180648A (en)
SE (1) SE9603285D0 (en)
WO (1) WO1998011103A1 (en)
ZA (1) ZA977809B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2003555A3 (en) 2000-07-27 2004-03-17 F. Hoffmann-La Roche Ag 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
TW201041580A (en) 2001-09-27 2010-12-01 Alcon Inc Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
US20050208151A1 (en) * 2003-10-30 2005-09-22 Entelos, Inc. Treatment of rheumatoid arthritis with FLIP antagonists
WO2007099385A1 (en) * 2006-03-01 2007-09-07 Glenmark Pharmaceuticals S.A. Dipeptidyl peptidase iv inhibitor compounds and compositions
TWI744723B (en) 2014-06-20 2021-11-01 美商基利科學股份有限公司 Synthesis of polycyclic-carbamoylpyridone compounds
EP3169337A1 (en) 2014-07-17 2017-05-24 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
BR112021013924A2 (en) 2019-01-18 2021-09-21 Astrazeneca Ab PCSK9 INHIBITORS AND METHODS OF USING THEM

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0817627B1 (en) * 1993-12-23 2005-03-09 Eli Lilly And Company Protein kinase c inhibitors

Also Published As

Publication number Publication date
ZA977809B (en) 1998-03-10
AR009732A1 (en) 2000-05-03
SA97180648A (en) 2005-12-03
WO1998011103A1 (en) 1998-03-19
SE9603285D0 (en) 1996-09-10

Similar Documents

Publication Publication Date Title
AU4477597A (en) New pharmaceutically active compounds
AU3616295A (en) Pharmaceutically active substituted aromatic compounds
AU7224396A (en) Pharmaceutically active quinazoline compounds
AU2186797A (en) Pharmaceutically useful compounds
ZA977807B (en) New pharmaceutically active compounds.
AU2270695A (en) Active compounds
AU2080199A (en) New pharmaceutically active compounds
AU4143397A (en) New pharmaceutically active compounds
AU4143297A (en) New pharmaceutically active compounds
GB9619122D0 (en) Pharmaceutically active compounds
GB9602667D0 (en) Pharmaceutically active compounds
GB9602173D0 (en) Pharmaceutically active compounds
GB9616477D0 (en) Pharmaceutically active compounds
GB9618487D0 (en) Pharmaceutically active compounds
GB9610892D0 (en) Pharmaceutically active compounds
GB9614385D0 (en) Pharmaceutically active compounds
GB9610474D0 (en) Pharmaceutically active compounds
GB9614386D0 (en) Pharmaceutically active compounds
GB9610499D0 (en) Pharmaceutically active compounds
GB9602668D0 (en) Pharmaceutically active compounds
AU2002315922A1 (en) Pharmaceutically active morpholinol
ZA978469B (en) New pharmaceutically active compounds.
ZA9811285B (en) New pharmaceutically active compounds
GB9510461D0 (en) Pharmaceutically active compounds
GB9501122D0 (en) Pharmaceutically active compounds